Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | GPR3 | P46089 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | PTGIR | P43119 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.32 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.30 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.30 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18927919 | 1.00 | MAPT (0.36) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL22161087 | 0.99 | MAPT (0.38) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL25891585 | 0.99 | MAPT (0.38) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL21966465 | 0.99 | MAPT (0.38) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL19660625 | 0.99 | MAPT (0.38) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL21973758 | 0.99 | MAPT (0.38) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL22161245 | 0.95 | GPR3 (0.39) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL22147245 | 0.95 | GPR3 (0.39) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL21966643 | 0.95 | ALDH1A1 (0.41) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL21966026 | 0.95 | ALDH1A1 (0.41) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230157160-A1 | COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING THE SAME, AND ELECTRONIC DEVICE | DUK SAN NEOLUX CO., LTD. (KR) | 2023-05-18 | — | — | US | disclosed |
| US-20230157160-A1 | COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING THE SAME, AND ELECTRONIC DEVICE | DUK SAN NEOLUX CO., LTD. (KR) | 2023-05-18 | — | — | US | disclosed |
| US-20230009845-A1 | ORGANIC ELECTRIC ELEMENT COMPRISING A PLURALITY OF EMISSION-AUXILIARY LAYERS AND ELECTRONIC DEVICE COMPRISING IT | DUK SAN NEOLUX CO., LTD. (KR) | 2023-01-12 | — | — | US | disclosed |
| US-11552253-B2 | Compound for organic electric device, organic electric device using same, and electronic device | DUK SAN NEOLUX CO., LTD. (KR) | 2023-01-10 | — | — | US | disclosed |
| US-20210184129-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD (KR) | 2021-06-17 | — | — | US | disclosed |
| WO-2019172623-A1 | COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2019-09-12 | — | — | WO | disclosed |
| WO-2017095075-A1 | COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING SAME, AND ELECTRONIC DEVICE | 덕산네오룩스 주식회사 | 2017-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11552253-B2 | Compound for organic electric device, organic electric device using same, and electronic device | OR10J3, OR51E2, ORAI2 | MAPT 1777/4885ALDH1A1 999/4885HPGD 1996/4885 |
| US-20210184129-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREOF | OR51E2, SLC39A11, WEE1 | MAPT 1639/4885ALDH1A1 2143/4885HPGD 3084/4885 |
| US-20230157160-A1 | COMPOUND FOR ORGANIC ELECTRIC DEVICE, ORGANIC ELECTRIC DEVICE USING THE SAME, AND ELECTRONIC DEVICE | OR10J3, OR51E2, ORAI2 | MAPT 1758/4885ALDH1A1 1082/4885HPGD 2154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.